The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2020
DOI: 10.1007/s12072-020-10076-4
|View full text |Cite
|
Sign up to set email alerts
|

Lymphocyte to monocyte ratio-based nomogram for predicting outcomes of hepatocellular carcinoma treated with sorafenib

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
21
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 18 publications
(23 citation statements)
references
References 38 publications
1
21
1
Order By: Relevance
“…In another study from our group, we showed that LMR measured prior to initiation of sorafenib in Asian and North American cohorts with advanced HCC was statistically associated with OS. We found that on considering sorafenib treatment in those patients, a new OS nomogram incorporating LMR can aid in educating patients, prognosticating and making prognosis-based decisions for physicians [ 20 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In another study from our group, we showed that LMR measured prior to initiation of sorafenib in Asian and North American cohorts with advanced HCC was statistically associated with OS. We found that on considering sorafenib treatment in those patients, a new OS nomogram incorporating LMR can aid in educating patients, prognosticating and making prognosis-based decisions for physicians [ 20 ].…”
Section: Discussionmentioning
confidence: 99%
“…Lastly, circulating monocytes have been reported to enhance tumor growth and potentiate immune escape of tumor cells [ 16 ] and their infiltration into HCC has been linked to a more aggressive behavior of the tumor [ 17 ]. Consequently, the neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR) and platelet to lymphocyte ratio (PLR) have been investigated as potential prognostic tools for HCC patients; particularly those receiving surgical resection [ 18 ], transplantation [ 19 ] and systemic treatment with sorafenib [ 20 ]. Much less is known about the prognostic roles of these ratios in patients treated by local ablation.…”
Section: Introductionmentioning
confidence: 99%
“…There is accumulating evidence indicating that preoperative serum biomarkers play a crucial role in predicting the prognosis of liver cancer patients. The lymphocyte-based indexes including PLR, NLR, LMR and SII have been introduced as potential prognostic markers for patients with HCC ( 16 , 24 ) and ICC ( 25 ) following curative liver resection. Liver function indexes including bilirubin, albumin, alkaline phosphatase (ALP), gamma-glutamyl transpeptidase (GGT), aspartate aminotransferase (AST) and alanine aminotransferase (ALT), are essential serum markers to determine the hepatic reserve function and feasibility of liver resection, on the basis of these indexes, several scoring systems including ALBI, FIB-4, AGR, AAPR and APRI, have been validated as efficient prognostic indicators for liver cancer patients ( 17 , 26 , 27 ).…”
Section: Discussionmentioning
confidence: 99%
“…Preoperative imaging data were extracted in the priority order of abdominal magnetic resonance imaging (MRI), computed tomography (CT), and abdominal ultrasound. Inflammatory indices were calculated according to the following formulas: NLR = neutrophil-to-lymphocyte ratio [ 18 ], PLR = platelet-to-lymphocyte ratio [ 19 ], and LMR = lymphocyte-to-monocyte ratio [ 20 ].…”
Section: Methodsmentioning
confidence: 99%